Cite
HARVARD Citation
Georgakopoulos, J. et al. (2019). Biologic switching between interleukin 17A antagonists secukinumab and ixekizumab: a 12‐week, multicenter, retrospective study. Journal of the European Academy of Dermatology and Venereology. pp. e7-e8. [Online].